Adjusted EPS improved, but core operating profit contracted. Joint-venture earnings and expense benefits did much of the work while seasonal cash flow remained negative. Three valuation routes cluster around $15. The dividend consumes nearly all guidance-midpoint earnings, leaving limited room for deleveraging. We require improving volume and cash coverage before paying for a durable recovery.
Analyst scenarios over roughly twelve months; price returns exclude dividends.
| Measure | Value |
|---|---|
| Bear | 10 |
| Base | 15 |
| Bull | 20 |
| Weighted | 14.5 |
| Reference | 14.12 |
| Scenario | Probability | 12-month value | vs $14.12 | What has to happen | The arithmetic |
|---|---|---|---|---|---|
| Bear | 30% | $10.00 | −29% | Volume weakness persists; dividend competes with debt service and investment. | Analyst assumption: $1.25 sustainable EPS × 8.0 = $10. |
| Base | 50% | $15.00 | +6% | Guidance holds, seasonal cash recovers, but operating sales remain weak. | $1.45 guidance midpoint × 10.5 = $15.23; FCF and EV routes triangulate near $15. |
| Bull | 20% | $20.00 | +42% | Volume stabilizes, operating margins recover and cash covers distributions. | Analyst assumption: $1.60 sustainable EPS × 12.5 = $20. |
| Computed weighted value: 30% × $10 + 50% × $15 + 20% × $20 = $14.50. These are judgmental probabilities, not statistical forecasts. | |||||
| Signpost | Now (Q1 FY2027) | Green if | Red if | Next check |
|---|---|---|---|---|
| Organic sales | −1.1% Q1 | At least 0% | Below −3% | Next quarterly release; review by 2027-01-31 |
| Grocery volume | −5.4% Q1 | Above −2% | At or below −5% | Next quarterly release; review by 2027-01-31 |
| Adjusted operating margin | 11.5% Q1 | At least 11.5% with volume improvement | Below 10% | Next quarterly release; review by 2027-01-31 |
| Cumulative free cash flow | −$127.9M Q1 | Positive at Q2 | Still negative at Q2 | Next quarterly release; review by 2027-01-31 |
| Year-end net leverage | 3.99× Q1 | Below 3.8× | Above 4.2× | FY2027 results; review by 2027-08-31 |
| Dividend cash coverage | 90% conversion illustration: $626.4M FCF vs $672M dividends | FCF exceeds annual dividend cash | FCF below dividend cash | FY2027 results; review by 2027-08-31 |
Thresholds are Charged Alpha decision rules, not company guidance. Dates are research review deadlines, not announced earnings dates.
The reference price is the saved September 29 quote of $14.12. The separate historical-price endpoint records $14.13 for that date; we retain both observations and use the quote consistently for valuation. It predates the earnings release, so we do not describe it as the market’s reaction to this quarter. The saved data does not establish a post-release trade. A high apparent dividend yield is the question this analysis investigates, not evidence that the security has a guaranteed return. The price chart uses unadjusted closes; it excludes reinvested distributions and should not be interpreted as total shareholder return.
| Reference date | Close |
|---|---|
| 2025-06-02 | 22.76 |
| 2026-09-29 | 14.13 |
| Period | Close-to-close change % |
|---|---|
| Q4 FY2025 | −4.367026496565263 |
| Q1 FY2026 | 5.4068814855270375 |
| Q2 FY2026 | −2.52808988764045 |
| Q3 FY2026 | −1.2722646310432628 |
| Q4 FY2026 | −0.4240282685512353 |
| Snapshot | Saved value | Interpretation |
|---|---|---|
| Market capitalization | $6,757.4M | FMP outstanding-share basis |
| Model equity value | $6,777.6M | Computed $14.12 × 480M diluted shares |
| 52-week range | $12.53–$20.32 | Saved provider quote |
| Beta | −0.049 | Provider estimate; not a loss forecast |
| Float | 474.9764M shares | Provider; differs from diluted weighted average |
| Employees | 17,400 | FY2026 annual report |
| Listing | NYSE common stock | No ADS ratio |
| Auditor | KPMG LLP | Annual report audit |
| All statement amounts USD millions unless specified. Derived ratios computed from saved primary-source inputs. | ||
The model deliberately uses the reported diluted quarterly share base throughout. The provider’s point-in-time market capitalization uses a different outstanding-share denominator; mixing those numbers would create false precision. Our equity and enterprise values are analytical approximations at the same reference price. History can show that expectations have weakened, but a falling price cannot establish an earnings floor. The operating and financing evidence must do that job. Historical reaction observations also mix business news with the wider market, so they are context rather than causal estimates.
Conagra reported $2,595.9M of sales for thirteen weeks ended August 30, 2026. The comparative column is thirteen weeks ended August 24, 2025. Reading those headers matters: the statement presents the current period first. Reported sales declined 1.4%, while organic sales declined 1.1%. Positive price and mix of 1.0% did not offset a 2.1% volume decline. Currency added 0.2 percentage points and divestitures subtracted 0.5 points from reported growth. Those are distinct measurement bridges, not interchangeable descriptions of demand.
| USD millions except EPS | Q1 FY2027 | Q1 FY2026 | Q4 FY2026 |
|---|---|---|---|
| Sales | 2595.9 | 2632.6 | 2882.1 |
| Adjusted operating profit | 297.9 | 310.7 | 336.5 |
| Net income | 174.3 | 164.5 | See Q4 release GAAP statement |
| Adjusted net income | 197.3 | 189.2 | 227.9 |
| Adjusted EPS | 0.41 | 0.39 | 0.47 |
| GAAP EPS | 0.36 | 0.34 | −3.37 |
| Q4 FY2026 has fourteen weeks; sequential comparisons are not normalized. Net-income prior-quarter basis corrected in source table below. | |||
| Period | Net sales |
|---|---|
| Q1 FY2025 | 2794.9 |
| Q2 FY2025 | 3195.1 |
| Q3 FY2025 | 2841.0 |
| Q4 FY2025 | 2781.8 |
| Q1 FY2026 | 2632.6 |
| Q2 FY2026 | 2979.1 |
| Q3 FY2026 | 2787.8 |
| Q4 FY2026 | 2882.1 |
| Q1 FY2027 | 2595.9 |
| Period | Adjusted EPS |
|---|---|
| Q1 FY2025 | 0.53 |
| Q2 FY2025 | 0.7 |
| Q3 FY2025 | 0.51 |
| Q4 FY2025 | 0.56 |
| Q1 FY2026 | 0.39 |
| Q2 FY2026 | 0.45 |
| Q3 FY2026 | 0.39 |
| Q4 FY2026 | 0.47 |
| Q1 FY2027 | 0.41 |
The saved FMP expectation was $0.2837 of EPS and $2,589.997M of revenue. Against the filing’s exact amounts, the computed surprises are 44.5% and 0.2%, respectively. The provider rounds reported sales to $2.6B; the filing is authoritative for calculations. A large percentage earnings beat off a low expectation does not mean a large improvement in the operating business. Adjusted EPS grew 5.1%, adjusted net income grew 4.3%, and adjusted operating profit declined 4.1%. Those three statements can all be true because investment income, interest and taxes sit between operations and shareholders.
Management reaffirmed rather than raised its full-year outlook: organic sales down 3% to 1%, adjusted operating margin of 10.0% to 10.5%, and adjusted EPS of $1.40 to $1.50. The quarter’s 11.5% adjusted margin is above that annual range, but seasonality and the remaining cost environment prevent annualizing it. This packet is release-led. The release advertised a September 30 live question-and-answer session; this analysis does not attribute comments to a transcript it has not reviewed.
Grocery & Snacks and Refrigerated & Frozen each generate just over a billion dollars of quarterly sales, but their demand problems differ. Grocery volume declined 5.4% as price and mix rose 3.4%. Frozen volume was almost flat, down 0.1%, while price and mix fell 1.5%. The first pattern raises elasticity and affordability questions; the second raises promotion and realization questions. Neither should be flattened into a single claim that every consumer abandoned the brands. The release also identifies dollar-share gains in selected categories, which can coexist with weak aggregate demand.
| Period | Q1 FY2026 | Q1 FY2027 |
|---|---|---|
| Grocery & Snacks | 1079.6 | 1051.1 |
| Refrigerated & Frozen | 1076.2 | 1053.8 |
| International | 212.3 | 218.1 |
| Foodservice | 264.5 | 272.9 |
| Period | Q1 FY2026 | Q1 FY2027 |
|---|---|---|
| Grocery & Snacks | 220.8 | 204.9 |
| Refrigerated & Frozen | 114.4 | 99.6 |
| International | 37.7 | 34.4 |
| Foodservice | 27.7 | 30.9 |
| Period | Volume % | Price/mix % |
|---|---|---|
| Grocery & Snacks | −5.4 | 3.4 |
| Refrigerated & Frozen | −0.1 | −1.5 |
| International | −0.7 | 1.6 |
| Foodservice | 2.5 | 0.8 |
Foodservice is the bright spot: organic sales rose 3.3% and adjusted operating profit increased 11.4%. Yet the company says customer-order timing contributed approximately 150 basis points to volume growth. A portion of the improvement therefore reflects when customers bought, not simply a stronger underlying run rate. International organic sales rose 0.9% while adjusted profit fell 8.6%, another reminder that revenue growth without margin resilience is insufficient. Productivity helped all four segments, but inflation and operating leverage absorbed much of the benefit.
For a recovery thesis, Grocery volume must improve without relying entirely on additional pricing, and Frozen must defend margin while stabilizing realization. Those are observable operating tests. Advertising investment may support the brands, but the economic payoff needs to appear in retention, volumes or pricing power over later quarters. We will not declare that investment successful merely because spending increased. Nor will we demand that every segment recover simultaneously; a credible broadening from the small Foodservice improvement into the two large retail businesses would be meaningful.
Adjusted operating profit was $297.9M, down $12.8M. Equity-method earnings rose $21.0M to $50.4M and net interest declined $2.0M. Adjusted tax expense increased $1.9M, and pension income was slightly lower. The resulting adjusted net-income gain was $8.1M. The identity of the earnings source matters because a wheat-milling joint venture has different cyclicality and cash distribution timing from selling Conagra’s branded foods. Treating the EPS increase as evidence that the retail operating margin recovered would skip the central fact of this print.
| Bridge item | USD millions |
|---|---|
| Operating | 268.4 |
| Pension | 5.9 |
| Interest | −91.8 |
| Equity income | 50.4 |
| Tax | −58.6 |
| Net | 174.3 |
| Measure | Value |
|---|---|
| Ardent earnings | 50.4 |
| Computed cash distributions | 18.199999999999996 |
Two favorable operating items also deserve attention. Adjusted SG&A includes a $10M benefit tied to prior-year incentive compensation, and gross profit includes about $4M of tariff refunds. Removing those two benefits mechanically would reduce adjusted operating profit to $283.9M, or an 8.6% decline versus the prior year. That is our sensitivity, not the company’s adjusted result. At the current adjusted tax rate, the two items are worth approximately 2.2 cents per diluted share. We do not label all productivity temporary or assume every refund must reverse.
A second illustrative stress removes those two benefits and the $21M increase in joint-venture income, while holding the 24.8% adjusted tax rate and 480M shares fixed. It produces about $0.36 of EPS from the reported $0.41. This is not a forecast or a replacement accounting measure: it isolates how much of the headline improvement depends on those assumptions. It also ignores interactions among costs, tax timing and commercial decisions. Its use is to direct the next-quarter questions toward sustainable operating profit and actual distributions.
| Measure | Value |
|---|---|
| Restructuring | 9.7 |
| Legal | 8.1 |
| Environment | 3 |
| Executive transition | 3.5 |
| Hedging | 5.2 |
| Measure | Value |
|---|---|
| Receivables | 23.73242420740398 |
| Inventory | 99.13716366579 |
The adjustments are disclosed, and adjusted earnings are useful for comparison, but useful does not mean costless. Restructuring can recur across different plans; litigation and environmental obligations can demand cash even when management excludes expense from its preferred profit measure. This quarter’s net legal adjustment also combines segment recoveries and corporate expense. The sign and location of each component matter. We do not add stock compensation back a second time merely because it appears in the cash-flow reconciliation. Doing that would invent an adjustment the company did not make.
The prior-year GAAP effective tax rate was 43.1%, compared with 25.2% now, reflecting tax effects associated with divestitures. That makes the GAAP EPS growth comparison less representative of operating momentum. Adjusted tax rates of 25.0% and 24.8% are much closer. Inventory increased from $1,905.4M at fiscal year-end to $2,154.0M, a computed 13.0% increase; that deserves observation, but quarter-end days are a rough proxy and cannot independently diagnose obsolete inventory or channel stuffing. The scorecard identifies questions, not allegations.
Quarterly negative cash conversion can be seasonal, especially when inventory is built ahead of demand. The red score therefore means cash has not yet confirmed earnings in this observation window. A fair review asks whether the cash arrives later, not whether one quarter meets an annual standard. Conversely, seasonal explanations should expire into evidence: inventory needs to sell, working capital needs to release, and earnings from the venture need to become distributable cash. A repeated negative result without a credible seasonal reversal would carry substantially more weight.
Operating cash flow was negative $4.2M and capital expenditure was $123.7M, producing negative free cash flow of $127.9M. Dividends of $167.5M and repurchases of $44.0M widened the cash shortfall after those allocations to $339.4M. The company issued $500M of long-term debt, while net debt rose $338.1M from fiscal year-end. Net debt nevertheless declined $193.2M from a year earlier. Both comparisons are valid; citing only the favorable annual comparison would obscure the sequential funding need.
| Period | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|
| 2026 | 1402.1 | 423.4 | 978.6999999999999 |
| 2025 | 1691.9 | 389.3 | 1302.6000000000001 |
| 2024 | 2015.6 | 388.1 | 1627.5 |
| Measure | Value |
|---|---|
| Model equity value | 6777.599999999999 |
| Total debt | 7760.1 |
| Cash | 371.6 |
| Net debt | 7388.5 |
| Balance-sheet measure | August 30, 2026 | May 31, 2026 |
|---|---|---|
| Cash | 371.6 | 218 |
| Notes and funded debt | 7760.1 | 7268.4 |
| Net debt | 7388.5 | 7050.4 |
| Inventory | 2154 | 1905.4 |
| Receivables | 677 | 658.2 |
| Equity | 6404.9 | 6357.6 |
| Goodwill | 8118.9 | 8119.3 |
| Brands / intangibles | 1819.8 | 1830.7 |
| All statement amounts USD millions unless specified. Derived ratios computed from saved primary-source inputs. | ||
Annualizing the reported quarterly dividend of $0.35 yields $1.40 a share, or $672M using our fixed 480M share assumption. That is a 96.6% payout against $1.45 guidance-midpoint adjusted EPS. The company guides to free-cash-flow conversion greater than 90%, not exactly 90%. At an illustrative 90%, cash generation would be $626.4M; at our base 95%, it would be $661.2M. Both illustrations are below annualized dividend cash. Coverage requires about 96.6% conversion at the midpoint before any buybacks or incremental debt reduction. Higher earnings or conversion could solve the gap; a promise of safety cannot.
To reach the illustrative 90% to 95% conversion outcomes after this first-quarter deficit, the remaining quarters would need $754.3M to $789.1M of free cash flow. That is a useful seasonal hurdle, not management’s quarterly forecast. The balance sheet contains large goodwill and intangible assets; subtracting them from book equity produces negative tangible equity. That does not make branded assets worthless, but it means book value is a weak liquidation cushion. Conagra’s approximately four-times net leverage and substantial interest bill make cash allocation a central part of equity valuation.
Our $15 base value is an analytical estimate over roughly twelve months, not a promise that the stock will reach it. We use three related routes because each highlights a different weakness. An earnings multiple is easy to audit but can overvalue low-cash-quality profits. A free-cash-flow yield tests payout capacity but depends on seasonal conversion. An enterprise-value route makes the debt claim explicit. Agreement among related methods does not create independent evidence; all three still rely on the same operating outlook.
$1.45 guidance midpoint × 10.5 = $15.23 per share. The 10.5× multiple is our judgment for a challenged, leveraged branded-food business.
$1.45 × 95% conversion / 9.5% required FCF yield = $14.50. The conversion and yield are assumptions; debt is not subtracted again from this equity-cash-flow route.
$696M adjusted net income / 76% after-tax factor + $360M interest + $400M assumed D&A = $1675.8M EBITDA including pension and JV income. Multiply by 8.75, subtract $7,388.5M net debt, divide by 480M shares = $15.16.
| EPS | 8× | 10.5× | 12.5× |
|---|---|---|---|
| 1.25 | 10.0 | 13.13 | 15.63 |
| 1.45 | 11.6 | 15.23 | 18.13 |
| 1.6 | 12.8 | 16.8 | 20.0 |
The EV route follows the company’s EBITDA convention, which includes equity-method earnings and pension income. It is not pure consolidated operating EBITDA. Forecast D&A of $400M is our assumption, anchored near the reported annual level, and the $7,388.5M net-debt deduction is held constant. At the reference price, our model enterprise value is $14,166.1M, or 8.45 times that forward EBITDA. At our selected 10.5 earnings multiple, the price implies sustainable EPS of about $1.34, below the guide midpoint but not a severe collapse.
We round the $14.50 to $15.23 route cluster to $15. The 30% bear, 50% base and 20% bull scenario mix yields $14.50, lower than the base case. Price upside to the base is only 6.2%, and to the weighted estimate only 2.7%, excluding dividends. High uncertainty leads us to require a 20% margin of safety, or a $12 review price, before considering a stronger entry case. Even there, operating deterioration could require a lower valuation; a price threshold never substitutes for the business tests. The bull case needs $1.60 sustainable EPS and a 12.5 multiple, while the bear uses $1.25 and eight times earnings.
The saved target consensus is $14, with a $12 low and $16 high, and the rating consensus is Hold. We also rate the stock Hold, with a slightly higher $15 base estimate. That agreement on the label should not erase the analytical difference: our argument is specifically about the cash available after investment, distributions and debt service, not simply whether the next EPS estimate will be met. The newest named targets in the saved feed predate the release; they are not post-earnings endorsements of this quarter.
| Period | Analyst count |
|---|---|
| Strong Buy | 1 |
| Buy | 5 |
| Hold | 15 |
| Sell | 4 |
| Strong Sell | 0 |
| Firm | Date | Target | Rating / timing |
|---|---|---|---|
| Evercore ISI | 2026-09-29 | $13 | In Line; before print |
| Deutsche Bank | 2026-09-18 | $13 | Hold; before print |
| UBS | 2026-07-16 | $14 | Neutral; before print |
| RBC Capital | 2026-07-16 | $14 | Sector Perform; before print |
| Charged Alpha | 2026-09-30 | $15 | HOLD 3/5; release reviewed |
| FMP saved target and ratings records, matched by firm and date. No invented recommendation attached to an unmatched item. | |||
| Period | Provider consensus EPS |
|---|---|
| 2027 | 1.44425 |
| 2028 | 1.49611 |
| 2029 | 1.57698 |
| Fiscal year ending | Consensus EPS | EPS analyst count | Revenue analyst count |
|---|---|---|---|
| 2027-05-31 | 1.44425 | 8 | 11 |
| 2028-05-31 | 1.49611 | 8 | 11 |
| 2029-05-31 | 1.57698 | 4 | 11 |
| All statement amounts USD millions unless specified. Derived ratios computed from saved primary-source inputs. | |||
The provider’s FY2027 EPS consensus of about $1.44 sits close to the company’s $1.45 midpoint. That leaves little room to argue that our base case depends on a large positive earnings revision. Later-year estimates imply gradual improvement, but coverage thins with distance and accounting definitions can differ. We do not splice the provider’s EBIT estimate directly into the company’s adjusted-margin guide; the latter is an operating measure with its own exclusions. A clean forecast comparison must align period, share basis and adjustment definitions before drawing conclusions.
Target changes are useful evidence of expectation formation but weak evidence of intrinsic value. Evercore’s saved September target increased to $13 from $12.50, and Deutsche Bank’s increased to $13 from $12. Those small increases occurred before today’s release and remained below the reference share price. We therefore do not present them as fresh buying pressure or a consensus upside calculation. Future research should compare actual post-print revisions with the cash and volume tests rather than assuming a target update validates every part of the thesis.
Management describes its priorities as restoring margins, increasing investment, reducing complexity and rebalancing capital allocation. The first quarter supplies evidence for investment through higher advertising expense and evidence for stable full-year expectations through reaffirmed guidance. It does not yet supply evidence that the core operating decline has ended. John Brase’s execution should be assessed on those specific outcomes. A new executive’s language is not itself a forecast upgrade, and expenses associated with a transition are still economic costs even when excluded from adjusted EPS.
| Commitment / decision | Observed evidence | Our assessment | Next test |
|---|---|---|---|
| Restore margin | Adjusted operating margin down 33 bps | Not yet demonstrated | Retail volume and margin jointly improve |
| Invest in brands | A&P $60.9M vs $52.9M | Spending increased | Demand response without margin erosion |
| Rebalance capital | Dividends $167.5M; buybacks $44M | Cash demands remain high | FCF covers allocations |
| Deleverage | 3.99×; year-end guide about 4× | Little guided near-term improvement | Below 3.8× earns greater confidence |
| Deliver outlook | $1.40–$1.50 EPS reaffirmed | Quarter beat not extrapolated | Annual cash and EPS both delivered |
| All statement amounts USD millions unless specified. Derived ratios computed from saved primary-source inputs. | |||
The annual report identifies Walmart and affiliates as approximately 29% of sales and the ten largest customers as approximately 60%. Large retailers can influence promotions, shelf placement, payment terms and negotiations. Brand spending must therefore earn its return with both shoppers and customers. The company’s common shares are the NYSE security analyzed here; no ADS conversion is required. Ardent Mills is a 44% equity-method investment, with roughly a one-month reporting lag, so its contribution should not be treated as cash already collected from a wholly owned operating unit.
Our five management questions are practical. How much of Grocery’s volume loss is distribution versus consumer response to price? Can Frozen improve realized pricing without giving back its volume stabilization? What proportion of the venture’s earnings can be distributed without impairing its own operations? What seasonal working-capital releases support the cash-conversion guide? Finally, what allocation takes priority if dividend coverage and the leverage target compete? Clear, quantified answers would reduce uncertainty more effectively than an isolated earnings beat. No unreviewed conference-call answer is assumed here.
| Rank | Risk | Likelihood | Impact | Evidence / decision use |
|---|---|---|---|---|
| 1 | Volume and pricing trade-off | High | High | Grocery volume −5.4%; Frozen price/mix −1.5% |
| 2 | Cash distribution crowding | High | High | Illustrative dividend coverage needs 96.6% conversion |
| 3 | Leverage and refinancing | Medium | High | Net debt $7.4B; interest $91.8M in quarter |
| 4 | Commodity / tariff volatility | High | Medium | Inflation offset productivity; refund helped quarter |
| 5 | Venture contribution reverses | Medium | Medium | Equity earnings +71.8% with smaller distributions |
| 6 | Legal and environmental cash | Medium | High | Reconciliation and cash-flow adjustments remain material |
| 7 | Retailer concentration | Medium | High | Walmart 29% of annual sales |
| All statement amounts USD millions unless specified. Derived ratios computed from saved primary-source inputs. | ||||
The bull case deserves more than a dismissive reference to a low multiple. Frozen volume is nearly stable, several categories gained dollar share, advertising is rising, and productivity is cushioning inflation. If those early signs broaden, earnings can recover while the market still assigns a depressed multiple. Strong seasonal cash generation could cover the dividend and reduce debt without requiring a dramatic revenue rebound. Under our bull assumptions, $1.60 of sustainable EPS at 12.5 times supports $20. The catalyst would be proof of operating durability, not simply another quarter with a favorable venture contribution.
The bear case is that pricing has reached consumer limits while the cost base remains difficult to shrink. Marketing investment and discounting can support volumes but consume the margin needed to fund debt and distributions. Reported adjusted EPS can remain superficially resilient for a time through corporate expense benefits or investment income even as core cash generation worsens. The dividend then becomes an allocation constraint. Our $10 bear outcome is not a liquidation estimate; it assumes $1.25 sustainable EPS and a lower eight-times valuation as investors demand more compensation for the uncertainty.
We land between those cases because the operating weakness is real but the company still produces substantial annual cash flow, has recognizable brands and has reaffirmed its outlook. The rating is Hold, with moderate conviction in the analytical stance and high uncertainty around value. Conviction and uncertainty describe different things: we can be confident that cash proof is necessary while recognizing a wide outcome range. Portfolio suitability, individual tax treatment and a viewer’s need for income are outside this company-level estimate. None of the scenarios makes a dividend declaration certain.
| Review window | What becomes observable | Positive evidence | Negative evidence |
|---|---|---|---|
| By 2027-01-31 | Next quarterly release and cash statement | Organic stabilization and positive cumulative FCF | Retail volume worsens; cash stays negative |
| Each dividend declaration | Board capital allocation | Distribution supported by cash outlook | Payout maintained only with rising debt |
| Next annual outlook update | EPS, margin and capex assumptions | Growth supported by operating profit | EPS support depends on non-operating items |
| By 2027-08-31 | FY2027 cash and leverage | Cash exceeds dividend; leverage below 3.8× | Cash falls short; leverage above 4.2× |
| Review deadlines are analyst scheduling assumptions; specific future release dates are not confirmed. | |||
The next useful catalyst is the first observation that can separate a seasonal cash deficit from a persistent funding problem. Positive cumulative free cash flow at the next quarterly check would be progress, but full coverage of annual distributions is the more demanding test. A favorable income statement with deteriorating working capital would keep the quality concern alive. Conversely, cash recovery with stable organic volume would reduce the chance that the earnings improvement depends mainly on items outside the branded-food operation.
These thresholds are intentionally dated so that the next packet can grade them. They are not instructions to buy or sell automatically. The $12 margin-of-safety review price is conditional on a still-valid $15 operating case, and the $20 bull outcome requires better sustainable earnings plus a higher multiple. We will change the model if the underlying evidence changes. The prior Q4 FY2026 local episode used a $15 fair value and focused on a dividend-reset angle; this episode focuses on the source and cash quality of Q1 earnings. No historical signpost packet was found to grade mechanically, and no performance success is claimed from an unverified prior delivery record.
| Quarter | Revenue $M | GAAP op $M | Adjusted op $M | GAAP EPS | Adjusted EPS | Diluted shares M |
|---|---|---|---|---|---|---|
| Q1 FY2025 | 2794.9 | 401.6 | 397.9 | 0.97 | 0.53 | 480.3 |
| Q2 FY2025 | 3195.1 | 402.6 | 490.1 | 0.59 | 0.7 | 479.3 |
| Q3 FY2025 | 2841.0 | 239.4 | 361.9 | 0.3 | 0.51 | 479.3 |
| Q4 FY2025 | 2781.8 | 321.0 | 384.6 | 0.53 | 0.56 | 479.5 |
| Q1 FY2026 | 2632.6 | 347.4 | 310.7 | 0.34 | 0.39 | 479.6 |
| Q2 FY2026 | 2979.1 | −597.6 | 335.8 | −1.39 | 0.45 | 479.0 |
| Q3 FY2026 | 2787.8 | 280.1 | 295.7 | 0.42 | 0.39 | 479.8 |
| Q4 FY2026 | 2882.1 | −1658.3 | 336.5 | −3.37 | 0.47 | 479.2 |
| Q1 FY2027 | 2595.9 | 268.4 | 297.9 | 0.36 | 0.41 | 480.0 |
| All statement amounts USD millions unless specified. Derived ratios computed from saved primary-source inputs. | ||||||
| Fiscal year | OCF $M | Capex $M | FCF $M | SBC $M | Buybacks $M | Dividends $M |
|---|---|---|---|---|---|---|
| 2026 | 1402.1 | 423.4 | 978.6999999999999 | 54.7 | 15.3 | 669.7 |
| 2025 | 1691.9 | 389.3 | 1302.6000000000001 | 41.5 | 64.0 | 669.2 |
| 2024 | 2015.6 | 388.1 | 1627.5 | 30.8 | 0.0 | 659.3 |
| All statement amounts USD millions unless specified. Derived ratios computed from saved primary-source inputs. | ||||||
Financial amounts are in millions of U.S. dollars unless explicitly labeled per share, ratios, days or percentages. Free cash flow is operating cash flow less additions to property, plant and equipment. Net debt includes notes payable, current debt installments and senior long-term debt, less cash. Ending-balance working-capital days use ninety-one days for the thirteen-week quarter; they are not average-balance turnover measures. Share-price comparisons exclude dividends. Non-GAAP measures follow the release definitions and should be read alongside the GAAP reconciliation, not as replacements for audited reporting.
Source eligibility was established from the September 30 Form 8-K, Items 2.02 and 9.01, and its saved Exhibit 99.1. The report is Q1 FY2027, not the older Q4 FY2026 episode. The recent SEC submission inventory contains historical 2018 transaction forms tied to the Pinnacle acquisition. The original transaction filing identifies that merger; the FY2026 annual report describes the acquired brands recognized at fair value in fiscal 2019 and settled acquisition financing. The historical transaction is completed, not a current pending-merger exclusion. The current inventory review found no unresolved late-report, contested-proxy, going-private or delisting flag. Ordinary proxy filings are not automatically contested elections.
The primary release, nine quarterly release tables, annual cash-flow statements, SEC submission inventory and dated provider snapshots are preserved with the local research dataset. All derived ratios and valuation outputs are computed in the accompanying calculation scripts. Forecast multiples, probabilities, conversion rates, capital assumptions and review thresholds are analytical choices and are labeled accordingly. No currency translation is required. The full historical reconciliation rows remain in the dataset so that annual impairment charges, divestiture gains and tax effects are not silently normalized out of the record.
The uncertainty assessment combines operating risk, financial leverage and the gap between accounting earnings and cash available for distribution. A higher dividend yield does not reduce those risks by itself. Likewise, the venture’s earnings are real reported income even when distribution timing differs; the appropriate response is to model the timing and sustainability, not to dismiss them. Our scenario prices should be read as transparent estimates under stated conditions. Future packets should update the same operating checkpoints, compare like periods, preserve the distinction between current and historical corporate events, and explain why any valuation assumption changed.